Click here to search courses using NAPNAP's previous Course Catalog layout.

Title
Category
Credits
Event date
Cost
Sedation & Analgesia Outside the Box: Choices and Challenges
  • Acute Care
  • Pharmacology CE
  • Controlled Substances CE
  • 1.25 Contact hours
$25.00
1.25 NAPNAP Contact Hour of which 1.25 contains pharmacology content and 1.25 is related to controlled substances. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non-members, this continuing education activity rate is $25. This course is a recorded presentation for NAPNAP's 2024 National Conference. Pain and sedation management in the pediatric population has traditionally focused on opioids and benzodiazepines, but there are many other options. We will review the benefits of using a multimodal strategy for pain and sedation management, including the use of alternative agents and administration routes, to ensure patient comfort. We will also review side effect prevention, including delirium assessment and management.
JPHC CE: Approaches to Treating Children With ADHD and Common Comorbidities
  • FREE for Members
  • Pharmacology CE
  • Psychopharmacology CE
  • Controlled Substances CE
  • 1.00 Contact hours
$10.00
1.0 NAPNAP contact hour of which 1.0 contain pharmacology content (Rx), (1.0 is related to psychopharmacology), (0.25 is related to controlled substance). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Attention Deficit Hyperactivity Disorder (ADHD) is the most common mental health disorder among children and adolescents, with a prevalence rate of 9.8% in children 3 to 17 years of age (Bitsko et al., 2022). The American Academy of Pediatrics (AAP) has published guidelines for treatment of ADHD in children and adolescents ages 4 to 17 years that address diagnosis, treatment and monitoring of ADHD (Wolraich et al., 2019). The AAP guidelines do not address treatment of children with co-morbidities but identify the treatment of ADHD in children with comorbidities as an area for future research. To address this gap, a review of ADHD treatment in children with comorbidities including anxiety, depression, substance use disorder (SUD), epilepsy, tic disorders (TD), oppositional defiant disorder (ODD), learning disabilities (LD), autism spectrum disorder (ASD) and sleep disorders was conducted. J Pediatr Health Care. (2025) 39, 318-325.